CDT Equity Inc.
USUSDCDT Equity Inc. (US:CDT) — Biotechnology: Pharmaceutical Preparations. Número de bolsas en las que cotizan las acciones de la empresa: 1. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.
Sobre la empresa
- Sitio web
- cdtequity.com
- Sector
- Health Care · Biotechnology: Pharmaceutical Preparations
- Sede central
- NAPLES, United States
- Consejero delegado
- James Bligh
- Empleados
- 4
- Acciones en circulación
- 6.31 M a 2026-07-15
- Capital flotante
- 22 431
- Capitalización bursátil
- 763 020 USD
- Insiders
- 32.85%
- Inversores institucionales
- 0.07%
- Industria (SIC)
- Pharmaceutical Preparations
- Ratio de reparto
- 0%
- FCF
- —
- Deuda
- 800 mil USD
- Racha de dividendos
- —
- Beneficios, FCF y dividendos pagados — para los 12 meses hasta 30.06.2026 (el último informe de la compañía).
Descripción
CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.
Bolsas y tickers
| Bolsa | Ticker | Moneda | Precio | Tipo |
|---|---|---|---|---|
| US USA Stocks | CDT | USD | 0.8 -4.31% | acciones ordinarias |
Dividendos
No se han encontrado pagos de dividendos (comprobado el 10.10.2026). Es probable que la empresa no reparta dividendos.
Noticias de esta semana
Aún no hay noticias del sitio web de la empresa.
Principales accionistas
| Titular | Participación | Acciones | Fecha del informe |
|---|---|---|---|
| Jane Street Group, LLC | 0.03% | 6 119 | 2026-06-30 |
| Citadel Advisors Llc | 0.02% | 3 230 | 2026-06-30 |
| Virtu Financial LLC | 0.01% | 2 724 | 2026-06-30 |
| Geode Capital Management… | 0.01% | 1 674 | 2026-06-30 |
| Xtx Topco Ltd | 0.01% | 1 292 | 2026-06-30 |
| Financial Management Pro… | 0.01% | 1 001 | 2026-06-30 |
| Tower Research Capital L… | 0% | 910 | 2026-06-30 |
| Fidelity Concord Street… | 0% | 59 | 2026-07-31 |
| Fidelity Concord Street… | 0% | 8 | 2026-07-31 |
